The Commission stresses that these threats are not distant or abstract. Some already impose heavy burdens; others carry low-probability but catastrophic potential.
Beyond new project approvals, the department cleared 10 share purchase or subscription agreements worth Rs 1.69 billion and 20 technology transfer agreements during the month.
The economic burden is substantial: Aedes-borne diseases alone impose an estimated average annual global cost of nearly $1.2 billion through healthcare spending, lost productivity and social disruption.
Beyond new project approvals, the department cleared 10 share purchase or subscription agreements worth Rs 1.69 billion and 20 technology transfer agreements during the month.
The economic burden is substantial: Aedes-borne diseases alone impose an estimated average annual global cost of nearly $1.2 billion through healthcare spending, lost productivity and social disruption.